CN105585525A - 一种高收率孟鲁司特钠的合成新方法 - Google Patents
一种高收率孟鲁司特钠的合成新方法 Download PDFInfo
- Publication number
- CN105585525A CN105585525A CN201610112340.2A CN201610112340A CN105585525A CN 105585525 A CN105585525 A CN 105585525A CN 201610112340 A CN201610112340 A CN 201610112340A CN 105585525 A CN105585525 A CN 105585525A
- Authority
- CN
- China
- Prior art keywords
- acid
- sodium salt
- montelukast
- montelukast sodium
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Quinoline Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610112340.2A CN105585525B (zh) | 2016-02-29 | 2016-02-29 | 一种孟鲁司特钠的合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610112340.2A CN105585525B (zh) | 2016-02-29 | 2016-02-29 | 一种孟鲁司特钠的合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105585525A true CN105585525A (zh) | 2016-05-18 |
CN105585525B CN105585525B (zh) | 2018-08-14 |
Family
ID=55925467
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610112340.2A Active CN105585525B (zh) | 2016-02-29 | 2016-02-29 | 一种孟鲁司特钠的合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105585525B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112724082A (zh) * | 2020-12-17 | 2021-04-30 | 江苏阿尔法药业有限公司 | 一种孟鲁司特钠药物中间体的制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008001213A1 (en) * | 2006-06-26 | 2008-01-03 | Aurobindo Pharma Limited | An improved process for the preparation of leukotriene receptor antagonist (montelukast sodium) |
WO2009113087A1 (en) * | 2008-01-07 | 2009-09-17 | Torrent Pharmaceuticals Ltd. | Montelukast benzhydryl piperazine salts and process for preparation thereof |
WO2010064109A2 (en) * | 2008-12-02 | 2010-06-10 | Mayuka Labs Private Limited | An improved process for the preparation of montelukast sodium and its intermediates |
CN102442947A (zh) * | 2011-11-01 | 2012-05-09 | 上海璎黎科技有限公司 | 孟鲁司特钠中间体的制备方法 |
CN103570619A (zh) * | 2013-11-08 | 2014-02-12 | 南京靖龙药物研发有限公司 | 一种孟鲁司特钠衍生物的制备方法 |
JP2015010049A (ja) * | 2013-06-27 | 2015-01-19 | 株式会社トクヤマ | モンテルカストアルキルエステルを製造する方法 |
-
2016
- 2016-02-29 CN CN201610112340.2A patent/CN105585525B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008001213A1 (en) * | 2006-06-26 | 2008-01-03 | Aurobindo Pharma Limited | An improved process for the preparation of leukotriene receptor antagonist (montelukast sodium) |
WO2009113087A1 (en) * | 2008-01-07 | 2009-09-17 | Torrent Pharmaceuticals Ltd. | Montelukast benzhydryl piperazine salts and process for preparation thereof |
WO2010064109A2 (en) * | 2008-12-02 | 2010-06-10 | Mayuka Labs Private Limited | An improved process for the preparation of montelukast sodium and its intermediates |
CN102442947A (zh) * | 2011-11-01 | 2012-05-09 | 上海璎黎科技有限公司 | 孟鲁司特钠中间体的制备方法 |
JP2015010049A (ja) * | 2013-06-27 | 2015-01-19 | 株式会社トクヤマ | モンテルカストアルキルエステルを製造する方法 |
CN103570619A (zh) * | 2013-11-08 | 2014-02-12 | 南京靖龙药物研发有限公司 | 一种孟鲁司特钠衍生物的制备方法 |
Non-Patent Citations (2)
Title |
---|
陈瀛等: "孟鲁司特钠合成路线图解", 《中国医药工业杂志》 * |
骆红英等: "孟鲁司特的合成研究", 《浙江大学硕士学位论文》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112724082A (zh) * | 2020-12-17 | 2021-04-30 | 江苏阿尔法药业有限公司 | 一种孟鲁司特钠药物中间体的制备方法 |
CN112724082B (zh) * | 2020-12-17 | 2022-05-13 | 江苏阿尔法药业股份有限公司 | 一种孟鲁司特钠药物中间体的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105585525B (zh) | 2018-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104876995B (zh) | 鹅去氧胆酸衍生物的制备方法 | |
CN103936671B (zh) | 孟鲁司特钠中间体的制备方法 | |
CN103613562B (zh) | 一种普拉克索的制备方法 | |
CN108440409B (zh) | 一种瑞巴匹特的绿色高效制备方法 | |
CN107056756A (zh) | 一种制备高纯度氯沙坦的方法 | |
CN104003934B (zh) | 6-氯-3-氟-2-吡啶甲酸的合成 | |
CN105585525A (zh) | 一种高收率孟鲁司特钠的合成新方法 | |
CN101778824B (zh) | 制备甲苯胺化合物的方法 | |
WO2016202252A1 (zh) | 一种合成d-对羟基苯甘氨酸甲酯的方法 | |
CN102746235B (zh) | 一种改进的制备咪达那新的方法 | |
CN102898357A (zh) | 用于制备依托考昔的中间体1-(6-甲基吡啶-3-基)-2-[4-(甲磺酰基)苯基]乙酮的新方法 | |
CN108948117B (zh) | 一种奥贝胆酸的合成方法 | |
CN105849091A (zh) | 一种制备异噁唑草酮的方法 | |
CN104529924B (zh) | 5-环丙基-4-[2-甲硫基-4-(三氟甲基)苯甲酰基]异恶唑的制备方法 | |
CN107721886A (zh) | 一种1‑芳基乙磺酸及其衍生物的制备方法 | |
JPWO2009063804A1 (ja) | N−カルバモイル−tert−ロイシンの製造法 | |
CN112094205B (zh) | 一种制备Fmoc-Ser(tBu)-OH的方法 | |
CN104672180A (zh) | 一种[(1s)-3-甲基-1-[[(2r)-2-甲基环氧乙基]羰基]丁基]氨基甲酸叔丁酯的手性制备方法 | |
CN104370961B (zh) | 一种相转移催化水解制备异辛基膦酸单异辛酯的方法 | |
CN103012261B (zh) | 一种孟鲁司特钠及其中间体的制备方法 | |
CN107089928A (zh) | N‑Boc‑L‑炔丙基甘氨酸的合成方法 | |
CN104844667A (zh) | 一种药物中间体卤素水解新方法 | |
CN103304405B (zh) | 一种选择性氯化的方法 | |
CN105753782A (zh) | 一种8-羟基喹啉及其合成方法 | |
CN109574951A (zh) | 一种非布索坦的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A synthetic method of montelukast sodium Effective date of registration: 20211224 Granted publication date: 20180814 Pledgee: Industrial and Commercial Bank of China Limited Feixian sub branch Pledgor: SHANDONG NEW TIME PHARMACEUTICAL Co.,Ltd. Registration number: Y2021980016193 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20221028 Granted publication date: 20180814 Pledgee: Industrial and Commercial Bank of China Limited Feixian sub branch Pledgor: SHANDONG NEW TIME PHARMACEUTICAL Co.,Ltd. Registration number: Y2021980016193 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A synthetic method of montelukast sodium Effective date of registration: 20221103 Granted publication date: 20180814 Pledgee: Industrial and Commercial Bank of China Limited Feixian sub branch Pledgor: SHANDONG NEW TIME PHARMACEUTICAL Co.,Ltd. Registration number: Y2022980020531 |